Details for 2017162101

Up to date per 01.04.2026

Actions

Title / Product Name

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HEMMUNG DER PCSK9-GENEXPRESSION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017162101

EP Publication Number

3249052

E-Number

1117765

Language

PCT Number

Publication Date

29.11.2017 A

10.04.2019 B1

Registration Date

10.04.2019

AT Publication Date

15.04.2019

Application Date

10.05.2007

Registration Number

Priorities

11.05.2006

799458 P

27.06.2006

817203 P

25.08.2006

840089 P

18.10.2006

829914 P

13.02.2007

901134 P

IPC

A61K 31/713 20060101AFI20180910BHEP

Maximum Duration of Protection

10.05.2027

Owner

Alnylam Pharmaceuticals, Inc.300 Third Street Cambridge, MA 02142US

Representative

No representatives present

Inventor

TAN, Pamelac/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US

BRAMLAGE, Birgitc/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US

FRANK-KAMENETSKY, Mariac/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US

FITZGERALD, Kevinc/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US

AKINC, Akinc/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US

KOTELIANSKI, Victor E.c/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US